# Developmental Research Program

> **NIH NIH P50** · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · 2021 · $80,443

## Abstract

The purpose of the Developmental Research Program (DRP) is to identify and support first-rate, pioneering
translational projects in lymphoma that, despite their potential, are not yet mature for full program status. All
members of the research community at City of Hope and University of Alabama Birmingham (UAB) are
encouraged to consider the opportunity. We have requested $50,000 per year to support this program, and
City of Hope and UAB will match these funds annually by $100,000 and $25,000, respectively. At least two
researchers per year receive awards, which are granted for up to two years. Funds can be devoted to research
supplies and minor equipment, personnel costs, and relevant meeting expenses. Promising investigations may
replace SPORE research projects that have either acquired funding as independent R01/P01 projects, or those
that have not satisfactorily progressed. Drs. Larry Kwak, Wing (John) Chan, and Ravi Bhatia, longstanding
leaders in their field, are the Developmental Program Directors. A request for applications will be advertised
and sent to the entire City of Hope and UAB research committees. Proposals from women and minority
applicants are encouraged. Proposed projects are reviewed on the basis of scientific merit, likelihood of benefit
to lymphoma patients, qualifications of key personnel, and the potential for interaction with the projects and
cores of the City of Hope Lymphoma SPORE. Selected projects are fully integrated into the overall SPORE.
Investigators funded through the DRP fully participate in SPORE activities, including monthly meetings,
allowing an open exchange of ideas and research goals. The SPORE also enhances interactions between
DRP researchers and investigators at other SPOREs and institutions. Funded scientists present regular
updates on their progress, receiving feedback and any needed problem solving. Over the last four years,
projects under the DRP have been reflective of our innovative research programs in lymphoma. Data have
contributed toward major specific aims in Projects 1 and 4 of the current SPORE and have generated
substantial progress. We are eager to assist a new round of investigators by helping to bring to fruition studies
with potential benefit to lymphoma patients and possibly those with other cancers, as well.

## Key facts

- **NIH application ID:** 10242164
- **Project number:** 5P50CA107399-14
- **Recipient organization:** BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
- **Principal Investigator:** LARRY W KWAK
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $80,443
- **Award type:** 5
- **Project period:** 2004-09-02 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10242164

## Citation

> US National Institutes of Health, RePORTER application 10242164, Developmental Research Program (5P50CA107399-14). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10242164. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*